Skip to main content

Advertisement

SpringerLink
Log in

Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice?

  • Review Article
  • Published:
Updates in Surgery Aims and scope Submit manuscript

Abstract

Since the introduction of Pap smear screening, the incidence and mortality of cervical cancer (CC) have been reduced drastically in USA and in other western states. Nevertheless, CC still remains the main cause of death from gynecological cancer in developing countries where screening programs are scant or inexistent. This evidence highlights the efficacy of screening, and the wide use of Human Papilloma Viruses (HPV) vaccines in developed countries. More and more people are, consequentially, undergoing a screening procedure, usually combined with HPV DNA test, increasing the early diagnosis of intraepithelial HPV-related lesions. The long transit time from early cervical lesion to invasive cancer provides an opportunity to identify pre-cancerous lesions where treatment result is maximum. In fact, when an invasive CC occurs, the overall survival rate strictly depends on stage of disease with an average survival of 70% at 5 years. Under the pressure of this reality, researches have made efforts to individuate cancer markers as indicator of specific cancer events. Some markers were showed to be able to detect those intraepithelial lesions have more chance to evolve to invasive forms (p16ink4a, p16, E-cadherin, Ki67, pRb, p53). Markers such as CEA, SCC-Ag, CD44, have been developed to detect invasive forms. Although cancer markers actually are not used only for early diagnosis, they may be useful in others fields of application such as evaluation and monitoring of treatments to improve diagnosis and treatment of CC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Denny L (2012) Cervical cancer: prevention and treatment. Discov Med 14:125–131

    PubMed  Google Scholar 

  2. Vitale SG, Laganà AS, Valenti G, La Rosa VL (2017) Comment on “Laparoscopic myomectomy of a symptomatic uterine leiomyoma in a 15-year-old adolescent”. J Pediatr Adolesc Gynecol 30:442–443. doi:10.1016/j.jpag.2016.11.013

    Article  PubMed  Google Scholar 

  3. Laganà AS, Vitale SG, Palmara V, Ban Frangez H, Triolo O (2017) Transvaginal specimen removal in minimally invasive surgery: feasibility and possible complications during the incision of the posterior vaginal wall. World J Urol 35:1155–1156. doi:10.1007/s00345-016-1955-7

    Article  PubMed  Google Scholar 

  4. Butticè S, Sener TE, Lucan VC, Lunelli L, Laganà AS, Vitale SG, Netsch C, Tanidir Y, Pappalardo R, Magno C (2017) Hybrid transvaginal NOTES nephrectomy: postoperative sexual outcomes. A three-center matched study. Urology 99:131–135. doi:10.1016/j.urology.2016.09.023

    Article  PubMed  Google Scholar 

  5. Laganà AS, Vitale SG, Trovato MA, Palmara VI, Rapisarda AM, Granese R, Sturlese E, De Dominici R, Alecci S, Padula F, Chiofalo B, Grasso R, Cignini P, D’Amico P, Triolo O (2016) Full-thickness excision versus shaving by laparoscopy for intestinal deep infiltrating endometriosis: rationale and potential treatment options. Biomed Res Int 2016:3617179. doi:10.1155/2016/3617179

    Article  PubMed  PubMed Central  Google Scholar 

  6. Laganà AS, Sapia F, Butticè S, Valenti G, Vitale SG (2016) Comment on “Efficacy and safety of skeletonized mesh implants for advanced pelvic organ prolapse: 12 month follow up”. World J Urol 34:1499–1500. doi:10.1007/s00345-016-1858-7

    Article  PubMed  Google Scholar 

  7. Vitale SG, Laganà AS, Rapisarda AM (2016) Letter to the editor: Comment on “Simultaneous treatment of anterior vaginal wall prolapse and stress urinary incontinence by using transobturator four arms polypropylene mesh”. Investig Clin Urol 57:150–151. doi:10.4111/icu.2016.57.2.150

    Article  PubMed  PubMed Central  Google Scholar 

  8. Vitale SG, Laganà AS, Gulino FA, Tropea A, Tarda S (2016) Prosthetic surgery versus native tissue repair of cystocele: literature review. Updates Surg 68:325–329. doi:10.1007/s13304-015-0343-y

    Article  PubMed  Google Scholar 

  9. Di Spiezio Sardo A, Vieira MDC, Laganà AS, Chiofalo B, Vitale SG, Scala M, De Falco M, Nappi C, Catena U, Bifulco G (2017) Combined systemic and hysteroscopic intra-amniotic injection of methotrexate associated with hysteroscopic resection for cervical pregnancy: a cutting-edge approach for an uncommon condition. Eurasian J Med 49:66–68. doi:10.5152/eurasianjmed.2017.16215

    Article  Google Scholar 

  10. Butticè S, Laganà AS, Mucciardi G, Marson F, Tefik T, Netsch C, Vitale SG, Sener E, Pappalardo R, Magno C (2016) Different patterns of pelvic ureteral endometriosis. What is the best treatment? Results of a retrospective analysis. Arch Ital Urol Androl 88:266–269. doi:10.4081/aiua.2016.4.266

    Article  PubMed  Google Scholar 

  11. Laganà AS, Vitale SG, Muscia V, Rossetti P, Buscema M, Triolo O, Rapisarda AM, Giunta L, Palmara V, Granese R, Frangez HB, Romano A (2017) Endometrial preparation with Dienogest before hysteroscopic surgery: a systematic review. Arch Gynecol Obstet 295:661–667. doi:10.1007/s00404-016-4244-1

    Article  PubMed  Google Scholar 

  12. Laganà AS, Giacobbe V, Triolo O, Granese R, Ban Frangez H, Vrtacnik-Bokal E, Ietto C, Palmara VI (2016) Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study. Gynecol Endocrinol 32:408–411. doi:10.3109/09513590.2015.1128409

    Article  PubMed  Google Scholar 

  13. Laganà AS, Santoro G, Triolo O, Giacobbe V, Certo R, Palmara V (2015) Hashimoto thyroiditis onset after laparoscopic removal of struma ovarii: an overview to unravel a rare and intriguing finding. Clin Exp Obstet Gynecol 42:673–678

    PubMed  Google Scholar 

  14. Laganà AS, Sofo V, Salmeri FM, Palmara VI, Triolo O, Terzic MM, Patrelli TS, Lukanovic A, Bokal EV, Santoro G (2016) Oxidative stress during ovarian torsion in pediatric and adolescent patients: changing the perspective of the disease. Int J Fertil Steril 9:416–423

    PubMed  Google Scholar 

  15. Laganà AS, Vitale SG, De Dominici R, Padula F, Rapisarda AM, Biondi A, Cianci S, Valenti G, Capriglione S, Frangez HB, Sturlese E (2016) Fertility outcome after laparoscopic salpingostomy or salpingectomy for tubal ectopic pregnancy A 12-years retrospective cohort study. Ann Ital Chir 87:461–465

    PubMed  Google Scholar 

  16. Vitale SG, Gasbarro N, Laganà AS, Sapia F, Rapisarda AMC, Valenti G, Trovato MA, Rossetti D, Chiofalo B, Barrasso G, Tinelli A, Corrado F (2016) Safe introduction of ancillary trocars in gynecological surgery: the “yellow island” anatomical landmark. Ann Ital Chir 87:608–611

    PubMed  Google Scholar 

  17. Giacobbe V, Rossetti D, Vitale SG, Rapisarda AM, Padula F, Laganà AS, Palmara VI (2016) Otorrhagia and nosebleed as first signs of intravascular absorption syndrome during hysteroscopy: from bench to bedside. Kathmandu Univ Med J (KUMJ) 14:87–89

    CAS  Google Scholar 

  18. Laganà AS, Colonese F, Colonese E, Sofo V, Salmeri FM, Granese R, Chiofalo B, Ciancimino L, Triolo O (2015) Cytogenetic analysis of epithelial ovarian cancer’s stem cells: an overview on new diagnostic and therapeutic perspectives. Eur J Gynaecol Oncol 36:495–505

    PubMed  Google Scholar 

  19. Bellia A, Vitale SG, Laganà AS, Cannone F, Houvenaeghel G, Rua S, Ladaique A, Jauffret C, Ettore G, Lambaudie E (2016) Feasibility and surgical outcomes of conventional and robot-assisted laparoscopy for early-stage ovarian cancer: a retrospective, multicenter analysis. Arch Gynecol Obstet 294:615–622. doi:10.1007/s00404-016-4087-9

    Article  PubMed  Google Scholar 

  20. Vitale SG, Marilli I, Lodato M, Tropea A, Cianci A (2013) The role of cytoreductive surgery in advanced-stage ovarian cancer: a systematic review. Updates Surg 65:265–270. doi:10.1007/s13304-013-0213-4

    Article  PubMed  Google Scholar 

  21. Laganà AS, Sofo V, Vitale SG, Triolo O (2016) Epithelial ovarian cancer inherent resistance: may the pleiotropic interaction between reduced immunosurveillance and drug-resistant cells play a key role? Gynecol Oncol Rep 18:57–58. doi:10.1016/j.gore.2016.09.004

    Article  PubMed  PubMed Central  Google Scholar 

  22. Vitale SG, Valenti G, Gulino FA, Cignini P, Biondi A (2016) Surgical treatment of high stage endometrial cancer: current perspectives. Updates Surg 68:149–154. doi:10.1007/s13304-015-0340-1

    Article  PubMed  Google Scholar 

  23. Rossetti D, Bogani G, Carnelli M, Vitale SG, Grosso G, Frigerio L (2014) Efficacy of IVF following conservative management of endometrial cancer. Gynecol Endocrinol 30:280–281. doi:10.3109/09513590.2014.892065

    Article  PubMed  Google Scholar 

  24. Vitale SG, Rossetti D, Tropea A, Biondi A, Laganà AS (2017) Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives. Updates Surg 69:29–34. doi:10.1007/s13304-017-0419-y

    Article  PubMed  Google Scholar 

  25. Cignini P, Vitale SG, Laganà AS, Biondi A, La Rosa VL, Cutillo G (2017) Preoperative work-up for definition of lymph node risk involvement in early stage endometrial cancer: 5-year follow-up. Updates Surg 69:75–82. doi:10.1007/s13304-017-0418-z

    Article  PubMed  Google Scholar 

  26. Vitale SG, Valenti G, Biondi A, Rossetti D, Frigerio L (2015) Recent trends in surgical and reconstructive management of vulvar cancer: review of literature. Updates Surg 67:367–371. doi:10.1007/s13304-015-0303-6

    Article  PubMed  Google Scholar 

  27. Benard VB, Thomas CC, King J, Massetti GM, Doria-Rose VP, Saraiya M, Centers for Disease C, Prevention (2014) Vital signs: cervical cancer incidence, mortality, and screening—United States, 2007–2012. MMWR Morb Mortal Wkly Rep 63:1004–1009

    PubMed  Google Scholar 

  28. Laganà AS, La Rosa V, Petrosino B, Vitale SG (2017) Comment on “Risk of developing major depression and anxiety disorders among women with endometriosis: a longitudinal follow-up study”. J Affect Disord 208:672–673. doi:10.1016/j.jad.2016.07.016

    Article  PubMed  Google Scholar 

  29. Vitale SG, La Rosa VL, Rapisarda AM, Laganà AS (2017) Comment on: “Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference”. J Psychosom Obstet Gynaecol 38:81–82. doi:10.1080/0167482X.2016.1244183

    Article  PubMed  Google Scholar 

  30. Vitale SG, La Rosa VL, Rapisarda AM, Laganà AS (2016) Impact of endometriosis on quality of life and psychological well-being. J Psychosom Obstet Gynaecol 18:1–3. doi:10.1080/0167482X.2016.1244185

    Google Scholar 

  31. Laganà AS, La Rosa VL, Rapisarda AM, Vitale SG (2017) Comment on: “Needs and priorities of women with endometrial and cervical cancer”. J Psychosom Obstet Gynaecol 38:85–86. doi:10.1080/0167482X.2016.1244186

    Article  PubMed  Google Scholar 

  32. Vitale SG, La Rosa VL, Rapisarda AM, Laganà AS (2017) Comment on: “Anxiety and depression in patients with advanced ovarian cancer: a prospective study”. J Psychosom Obstet Gynaecol 38:83–84. doi:10.1080/0167482X.2016.1244182

    Article  PubMed  Google Scholar 

  33. Vitale SG, La Rosa VL, Rapisarda AM, Laganà AS (2017) Psychology of infertility and assisted reproductive treatment: the Italian situation. J Psychosom Obstet Gynaecol 38:1–3. doi:10.1080/0167482X.2016.1244184

    Article  PubMed  Google Scholar 

  34. Vitale SG, Petrosino B, La Rosa VL, Laganà AS (2017) Comment on “Differences in psychophysical well-being and signs of depression in couples undergoing their first consultation for assisted reproduction technology (ART): an Italian pilot study”. Eur J Obstet Gynecol Reprod Biol 211:210–211. doi:10.1016/j.ejogrb.2016.10.029

    Article  PubMed  Google Scholar 

  35. Laganà AS, La Rosa VL, Rapisarda AM, Vitale SG (2017) Comment on: “Effect on sexual function of patients and patients’ spouses after midurethal sling procedure for stress urinary incontinence: a prospective single center study”. Low Urin Tract Symptoms 9:62. doi:10.1111/luts.12164

    Article  PubMed  Google Scholar 

  36. Vitale SG, Petrosino B, La Rosa VL, Rapisarda AM, Laganà AS (2016) A systematic review of the association between psychiatric disturbances and endometriosis. J Obstet Gynaecol Can 38:1079–1080. doi:10.1016/j.jogc.2016.09.008

    Article  PubMed  Google Scholar 

  37. Muscatello MR, Lorusso S, Bruno A, Reale R, Ciura GL, Laganà AS, Retto G, Sturlese E, Zoccali RA (2016) Anger in women treated with assisted reproductive technology (ART): effects on mother and newborn. J Matern Fetal Neonatal Med 29:813–817. doi:10.3109/14767058.2015.1019459

    Article  PubMed  Google Scholar 

  38. Laganà AS, Condemi I, Retto G, Muscatello MR, Bruno A, Zoccali RA, Triolo O, Cedro C (2015) Analysis of psychopathological comorbidity behind the common symptoms and signs of endometriosis. Eur J Obstet Gynecol Reprod Biol 194:30–33. doi:10.1016/j.ejogrb.2015.08.015

    Article  PubMed  Google Scholar 

  39. Vitale SG, La Rosa VL, Rapisarda AM, Laganà AS (2016) Comment on: “The consequences of gynaecological cancer in patients and their partners from the sexual and psychological perspective”. Prz Menopauzalny 15:186–187. doi:10.5114/pm.2016.63501

    PubMed  PubMed Central  Google Scholar 

  40. Laganà AS, La Rosa VL, Rapisarda AM, Platania A, Vitale SG (2017) Psychological impact of fertility preservation techniques in women with gynaecological cancer. Ecancermedicalscience 11:ed62. doi:10.3332/ecancer.2017.ed62

    Article  PubMed  PubMed Central  Google Scholar 

  41. Ferranti G, Prosperi Porta R, La Rosa VL, Vitale SG, Laganà AS (2017) Reflections on treatments for infertility and the possible occurrence of ovarian carcinomas. Recent Prog Med 108:136–140. doi:10.1701/2656.27236

    Google Scholar 

  42. Perkins AC, Skinner EN (2016) A review of the current cervical cancer screening guidelines. N C Med J 77:420–422. doi:10.18043/ncm.77.6.420

    PubMed  Google Scholar 

  43. Zhang HS, Postigo AA, Dean DC (1999) Active transcriptional repression by the Rb–E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition. Cell 97(53–6):1

    Google Scholar 

  44. Volgareva G, Zavalishina L, Andreeva Y, Frank G, Krutikova E, Golovina D, Bliev A, Spitkovsky D, Ermilova V, Kisseljov F (2004) Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells. BMC Cancer 4:58. doi:10.1186/1471-2407-4-58

    Article  PubMed  PubMed Central  Google Scholar 

  45. Vitale SG, Valenti G, Rapisarda AMC, Calì I, Marilli I, Zigarelli M, Sarpietro G, Cianci A (2016) P16INK4a as a progression/regression tumour marker in LSIL cervix lesions: our clinical experience. Eur J Gynaecol Oncol 37:685–688

    Google Scholar 

  46. Bergeron C, Ikenberg H, Sideri M, Denton K, Bogers J, Schmidt D, Alameda F, Keller T, Rehm S, Ridder R, Group PS (2015) Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results. Cancer Cytopathol 123:373–381. doi:10.1002/cncy.21542

    Article  CAS  PubMed  Google Scholar 

  47. Carcopino X, Henry M, Mancini J, Giusiano S, Boubli L, Olive D, Tamalet C (2012) Significance of HPV 16 and 18 viral load quantitation in women referred for colposcopy. J Med Virol 84:306–313. doi:10.1002/jmv.23190

    Article  PubMed  Google Scholar 

  48. Haedicke J, Iftner T (2016) A review of the clinical performance of the Aptima HPV assay. J Clin Virol 76(Suppl 1):S40–S48. doi:10.1016/j.jcv.2015.10.027

    Article  CAS  PubMed  Google Scholar 

  49. Cattani P, Zannoni GF, Ricci C, D’Onghia S, Trivellizzi IN, Di Franco A, Vellone VG, Durante M, Fadda G, Scambia G, Capelli G, De Vincenzo R (2009) Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. J Clin Microbiol 47:3895–3901. doi:10.1128/JCM.01275-09

    Article  PubMed  PubMed Central  Google Scholar 

  50. Frega A, Sesti F, Lombardi D, Votano S, Sopracordevole F, Catalano A, Milazzo GN, Lombardo R, Assorgi C, Olivola S, Chiusuri V, Ricciardi E, French D, Moscarini M (2014) Assessment of HPV-mRNA test to predict recurrent disease in patients previously treated for CIN 2/3. J Clin Virol 60:39–43. doi:10.1016/j.jcv.2014.01.017

    Article  CAS  PubMed  Google Scholar 

  51. Demirel D, Akyurek N, Ramzy I (2013) Diagnostic and prognostic significance of image cytometric DNA ploidy measurement in cytological samples of cervical squamous intraepithelial lesions. Cytopathology 24:105–112. doi:10.1111/cyt.12039

    Article  CAS  PubMed  Google Scholar 

  52. David O, Cabay RJ, Pasha S, Dietrich R, Leach L, Guo M, Mehrotra S (2009) The role of deeper levels and ancillary studies (p16(Ink4a) and ProExC) in reducing the discordance rate of Papanicolaou findings of high-grade squamous intraepithelial lesion and follow-up cervical biopsies. Cancer 117:157–166. doi:10.1002/cncy.20020

    PubMed  Google Scholar 

  53. Rodolakis A, Biliatis I, Symiakaki H, Kershnar E, Kilpatrick MW, Haidopoulos D, Thomakos N, Antsaklis A (2012) Role of chromosome 3q26 gain in predicting progression of cervical dysplasia. Int J Gynecol Cancer 22:742–747. doi:10.1097/IGC.0b013e31825104bd

    Article  PubMed  Google Scholar 

  54. Liu P, Iden M, Fye S, Huang YW, Hopp E, Chu C, Lu Y, Rader JS (2017) Targeted, deep sequencing reveals full methylation profiles of multiple HPV types and potential biomarkers for cervical cancer progression. Cancer Epidemiol Biomark Prev 26:642–650. doi:10.1158/1055-9965.EPI-16-0368

    Article  CAS  Google Scholar 

  55. Bhat S, Kabekkodu SP, Noronha A, Satyamoorthy K (2016) Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer. Biochimie 121:298–311. doi:10.1016/j.biochi.2015.12.018

    Article  CAS  PubMed  Google Scholar 

  56. Vetvicka V, Laganà AS, Salmeri FM, Triolo O, Palmara VI, Vitale SG, Sofo V, Kralickova M (2016) Regulation of apoptotic pathways during endometriosis: from the molecular basis to the future perspectives. Arch Gynecol Obstet 294:897–904. doi:10.1007/s00404-016-4195-6

    Article  CAS  PubMed  Google Scholar 

  57. Laganà AS, Salmeri FM, Triolo O, Vitale SG, Granese R, Sofo V (2016) Comments on “rhTNFR: Fc suppresses the development of endometriosis in a mouse model by downregulating cell proliferation and invasiveness”. Reprod Sci. doi:10.1177/1933719116653838

    PubMed  Google Scholar 

  58. Maniglio P, Ricciardi E, Laganà AS, Triolo O, Caserta D (2016) Epigenetic modifications of primordial reproductive tract: a common etiologic pathway for Mayer–Rokitansky–Kuster–Hauser syndrome and endometriosis? Med Hypotheses 90:4–5. doi:10.1016/j.mehy.2016.02.015

    Article  CAS  PubMed  Google Scholar 

  59. Laganà AS, Triolo O, Salmeri FM, Granese R, Palmara VI, Ban Frangez H, Vrtcnik Bokal E, Sofo V (2016) Natural Killer T cell subsets in eutopic and ectopic endometrium: a fresh look to a busy corner. Arch Gynecol Obstet 293:941–949. doi:10.1007/s00404-015-4004-7

    Article  PubMed  Google Scholar 

  60. Sofo V, Gotte M, Laganà AS, Salmeri FM, Triolo O, Sturlese E, Retto G, Alfa M, Granese R, Abrao MS (2015) Correlation between dioxin and endometriosis: an epigenetic route to unravel the pathogenesis of the disease. Arch Gynecol Obstet 292:973–986. doi:10.1007/s00404-015-3739-5

    Article  CAS  PubMed  Google Scholar 

  61. Salmeri FM, Laganà AS, Sofo V, Triolo O, Sturlese E, Retto G, Pizzo A, D’Ascola A, Campo S (2015) Behavior of tumor necrosis factor-alpha and tumor necrosis factor receptor 1/tumor necrosis factor receptor 2 system in mononuclear cells recovered from peritoneal fluid of women with endometriosis at different stages. Reprod Sci 22:165–172. doi:10.1177/1933719114536472

    Article  PubMed  PubMed Central  Google Scholar 

  62. Sturlese E, Salmeri FM, Retto G, Pizzo A, De Dominici R, Ardita FV, Borrielli I, Licata N, Laganà AS, Sofo V (2011) Dysregulation of the Fas/FasL system in mononuclear cells recovered from peritoneal fluid of women with endometriosis. J Reprod Immunol 92:74–81. doi:10.1016/j.jri.2011.08.005

    Article  CAS  PubMed  Google Scholar 

  63. Laganà AS, Salmeri FM, Vitale SG, Triolo O, Gotte M (2017) Stem cell trafficking during endometriosis. Reprod Sci. doi:10.1177/1933719116687661

    PubMed  Google Scholar 

  64. Kruszyna L, Lianeri M, Roszak A, Jagodzinski PP (2010) HER2 codon 655 polymorphism is associated with advanced uterine cervical carcinoma. Clin Biochem 43:545–548. doi:10.1016/j.clinbiochem.2009.12.016

    Article  CAS  PubMed  Google Scholar 

  65. Sousa H, Oliveira S, Santos AM, Catarino R, Moutinho J, Medeiros R (2014) Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer. Tumour Biol 35:2561–2564. doi:10.1007/s13277-013-1337-3

    Article  CAS  PubMed  Google Scholar 

  66. Yeasmin S, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Iida K, Otsuki Y, Kobayashi H, Nakayama S, Miyazaki K (2010) Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes. Gynecol Oncol 117:409–416. doi:10.1016/j.ygyno.2010.03.004

    Article  CAS  PubMed  Google Scholar 

  67. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G (2000) Overexpression of hypoxia-inducible factor1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 60:4693–4696

    CAS  PubMed  Google Scholar 

  68. Tanaka T, Terai Y, Kogata Y, Ashihara K, Maeda K, Fujiwara S, Yoo S, Tanaka Y, Tsunetoh S, Sasaki H, Kanemura M, Tanabe A, Ohmichi M (2015) CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer. Oncol Rep 34:2282–2288. doi:10.3892/or.2015.4257

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Landt S, Jeschke S, Koeninger A, Thomas A, Heusner T, Korlach S, Ulm K, Schmidt P, Blohmer JU, Lichtenegger W, Sehouli J, Kuemmel S (2010) Tumor-specific correlation of tumor M2 pyruvate kinase in pre-invasive, invasive and recurrent cervical cancer. Anticancer Res 30:375–381

    CAS  PubMed  Google Scholar 

  70. Jiang J, Wei LH, Li YL, Wu RF, Xie X, Feng YJ, Zhang G, Zhao C, Zhao Y, Chen Z (2010) Detection of TERC amplification in cervical epithelial cells for the diagnosis of high-grade cervical lesions and invasive cancer: a multicenter study in China. J Mol Diagn 12:808–817. doi:10.2353/jmoldx.2010

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy

    Gaetano Valenti, Alessandro Tropea & Antonio Biondi

  2. Unit of Gynecology and Obstetrics, Department of Human Pathology in Adulthood and Childhood “G. Barresi”, University of Messina, Via C. Valeria 1, 98125, Messina, Italy

    Salvatore Giovanni Vitale & Antonio Simone Laganà

Authors
  1. Gaetano Valenti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Salvatore Giovanni Vitale
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alessandro Tropea
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antonio Biondi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antonio Simone Laganà
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antonio Simone Laganà.

Ethics declarations

Funding

The work was not supported by any grant/fund.

Conflict of interest

The authors have no proprietary, financial, professional or other personal interest of any nature in any product, service or company. The authors alone are responsible for the content and writing of the paper.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Valenti, G., Vitale, S.G., Tropea, A. et al. Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice?. Updates Surg 69, 441–449 (2017). https://doi.org/10.1007/s13304-017-0491-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13304-017-0491-3

Keywords

Search

Navigation